These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 21778257

  • 1. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD.
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
    Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR, Gatzoulis MA, E Handler C, Howard LS, Johnson M, Kiely DG, Lordan JL, Peacock AJ, Pepke-Zaba J, Schreiber BE, Sheares KKK, Wort SJ, Corris PA, National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland.
    J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
    [Abstract] [Full Text] [Related]

  • 4. Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, Benza RL.
    Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
    [Abstract] [Full Text] [Related]

  • 5. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ, Chung L, Zamanian RT, Turner M, McGoon MD.
    Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
    [Abstract] [Full Text] [Related]

  • 6. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ, Ivy DD, Foreman AJ, McGoon MD, Rosenzweig EB.
    Am J Cardiol; 2014 Jan 01; 113(1):147-55. PubMed ID: 24176071
    [Abstract] [Full Text] [Related]

  • 7. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ.
    Chest; 2012 Feb 01; 141(2):363-373. PubMed ID: 21757572
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
    Takahashi Y, Yamamoto K, Sakao S, Takeuchi T, Suda R, Tanabe N, Tatsumi K.
    BMC Pulm Med; 2021 Mar 16; 21(1):89. PubMed ID: 33726742
    [Abstract] [Full Text] [Related]

  • 10. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD.
    Circulation; 2012 Jan 03; 125(1):113-22. PubMed ID: 22086881
    [Abstract] [Full Text] [Related]

  • 11. Portopulmonary hypertension: survival and prognostic factors.
    Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jaïs X, Yaïci A, Humbert M, Simonneau G, Sitbon O.
    Am J Respir Crit Care Med; 2008 Sep 15; 178(6):637-43. PubMed ID: 18617641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O.
    Hepatology; 2017 May 15; 65(5):1683-1692. PubMed ID: 27997987
    [Abstract] [Full Text] [Related]

  • 14. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW.
    Circulation; 2015 Dec 22; 132(25):2403-11. PubMed ID: 26510696
    [Abstract] [Full Text] [Related]

  • 15. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
    Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, Feldkircher K, Turner M, McGoon MD.
    Chest; 2011 Jan 22; 139(1):128-37. PubMed ID: 20558556
    [Abstract] [Full Text] [Related]

  • 16. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.
    Circulation; 2010 Jul 13; 122(2):164-72. PubMed ID: 20585012
    [Abstract] [Full Text] [Related]

  • 17. Portopulmonary hypertension.
    Krowka MJ.
    Semin Respir Crit Care Med; 2012 Feb 13; 33(1):17-25. PubMed ID: 22447257
    [Abstract] [Full Text] [Related]

  • 18. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN.
    Transplantation; 2017 Jul 13; 101(7):1609-1615. PubMed ID: 28207639
    [Abstract] [Full Text] [Related]

  • 19. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ, Jardim CV, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R.
    J Am Coll Cardiol; 2010 Aug 24; 56(9):715-20. PubMed ID: 20723801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.